These drugs , Rybelsus and Wegovy, represent a groundbreaking shift in the way treating type 2 diabetes and, increasingly, excess weight. They operate as GLP-1 receptor agonists , mimicking the action of a https://glp-1-patch647008.wikicommunications.com/user